Jeffrey A. Hubbell

Jeff is a professor and founder of the Institute of Bioengineering at the Ecole Polytechnique Fédérale de Lausanne (Swiss Federal Institute of Technology, EPFL), and a professor at the Institute of Molecular Engineering at the University of Chicago. His research focuses on engineering approaches to immunomodulation, drug delivery, and regenerative medicine. Jeff has successfully spun-out several companies based on technology from his laboratories, co-founding Focal, Inc. (Lexington, MA) and founding Kuros Biosurgery AG (Zurich, Switzerland). He is a fellow of the American Institute of Medical and Biological Engineering and a Member of the National Academy of Engineering.

Jeffrey A. Hubbell is the Co-Founder & Chief Scientific Officer at Anokion, based in Switzerland, Europe. With a background in Biotechnology, Jeffrey A. Hubbell has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.